By Matthew Bultman ( September 29, 2015, 6:02 PM EDT) -- Nexium buyers who lost at trial in the pay-for-delay multidistrict litigation against AstraZeneca PLC and Ranbaxy Inc. have asked a federal court not to award the drugmakers more than $423,000 in costs, saying it's an issue that would better be decided after appeal....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.